These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11521373)

  • 1. [The role of quantitative determination of the volume fraction of interstitial collagen and fibronectin in the pathogenesis of myocardial remodeling in dilated cardiomyopathy].
    Sisakian S; Gukasian LV; Mkrtshian LG; Kamalov GG; Avakian SA
    Klin Med (Mosk); 2001; 79(6):24-6. PubMed ID: 11521373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences in myocardial work of the left ventricle in patients with idiopathic dilated cardiomyopathy: Implications for the surgical technique used for left ventriculoplasty.
    Yanagida R; Sugawara M; Kawai A; Koyanagi H
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):600-7. PubMed ID: 11547316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.
    Timonen P; Magga J; Risteli J; Punnonen K; Vanninen E; Turpeinen A; Tuomainen P; Kuusisto J; Vuolteenaho O; Peuhkurinen K
    Int J Cardiol; 2008 Mar; 124(3):293-300. PubMed ID: 17442428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative characteristics of left ventricular remodeling in dilatation cardiomyopathy and ischemic disease].
    Sisakian AS; Eganian GA; Kamalov GG
    Klin Med (Mosk); 1997; 75(12):23-6. PubMed ID: 9503806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extreme reverse remodeling in a patient with dilated cardiomyopathy.
    Vidic A; McCann P; Ramirez Romero JM; Hauptman PJ
    Circ Heart Fail; 2014 Nov; 7(6):1063-5. PubMed ID: 25415960
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of myocardial fibrillar collagen in ventricular remodeling and function.
    Janicki JS; Brower GL
    J Card Fail; 2002 Dec; 8(6 Suppl):S319-25. PubMed ID: 12555139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy.
    Herpel E; Pritsch M; Koch A; Dengler TJ; Schirmacher P; Schnabel PA
    Histopathology; 2006 May; 48(6):736-47. PubMed ID: 16681691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy.
    Westenberg JJ; Braun J; Van de Veire NR; Klautz RJ; Versteegh MI; Roes SD; van der Geest RJ; de Roos A; van der Wall EE; Reiber JH; Bax JJ; Dion RA
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1247-52; discussion 1252-3. PubMed ID: 18544363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
    Tuunanen H; Engblom E; Naum A; Scheinin M; Någren K; Airaksinen J; Nuutila P; Iozzo P; Ukkonen H; Knuuti J
    J Card Fail; 2006 Oct; 12(8):644-52. PubMed ID: 17045185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ovine model of postinfarction dilated cardiomyopathy.
    Moainie SL; Gorman JH; Guy TS; Bowen FW; Jackson BM; Plappert T; Narula N; St John-Sutton MG; Narula J; Edmunds LH; Gorman RC
    Ann Thorac Surg; 2002 Sep; 74(3):753-60. PubMed ID: 12238835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of echocardiography in the diagnosis of dilated cardiomyopathy].
    Gritsiuk AI; Amosova EN; Kol'chenko VV
    Kardiologiia; 1987 Apr; 27(4):29-32. PubMed ID: 3599630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in myocardial collagen content before and after left ventricular assist device application in dilated cardiomyopathy.
    Liang H; Müller J; Weng YG; Wallukat G; Fu P; Lin HS; Bartel S; Knosalla C; Pregla R; Hetzer R
    Chin Med J (Engl); 2004 Mar; 117(3):401-7. PubMed ID: 15043781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy.
    Tziakas DN; Chalikias GK; Papaioakeim M; Hatzinikolaou EI; Stakos DA; Tentes IK; Papanas N; Kortsaris A; Maltezos E; Hatseras DI
    Am J Cardiol; 2005 Nov; 96(10):1449-51. PubMed ID: 16275197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic possibilities of Valsalva's test for detection of left-ventricular dysfunction in ischemic heart disease].
    Sivkov II; Chebyshev NS; Kuznetsov AB; Godin VA
    Sov Med; 1991; (3):57-60. PubMed ID: 1882295
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA; Neglia D; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):778-82. PubMed ID: 18607240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.